# A Study in Patients With Trichotillomania

> **NCT03797521** · PHASE2 · COMPLETED · sponsor: **Promentis Pharmaceuticals, Inc.** · enrollment: 128 (actual)

## Conditions studied

- Trichotillomania

## Interventions

- **DRUG:** SXC-2023
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03797521
- **Lead sponsor:** Promentis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-19
- **Primary completion:** 2019-12-02
- **Final completion:** 2019-12-16
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03797521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03797521, "A Study in Patients With Trichotillomania". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03797521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*